RNU7-95P

Across TCGA pan-cancer cohorts, RNU7-95P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-95P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-95P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-95P expression acts as an unfavorable survival marker.

BLCA, BRCA, and THCA are the cancer types where RNU7-95P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.109	0.617	<.001	72	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
THCA	DFS	Tertile	All	0.136	0.842	.002	36	view →
PAAD	OS	Tertile	All	0.200	0.589	.006	18	view →
ESCA	OS	Tertile	All	0.280	0.544	.035	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-95P–BLCA (DFS)

Open the BLCA breakdown →